AIM ImmunoTech CFO Ellen Lintal to retire effective March 31, 2022

AIM ImmunoTech Inc.

Ellen Lintal informed Company on Sept 20, 2021 of her retirement as CFO.
Retirement and contract non-renewal effective March 31, 2022.
Lintal will stay post-retirement on a contractual basis to assist with SEC filings.
CFO departure timed to allow completion of annual report on Form 10-K.
CEO Thomas K. Equels signed the filing.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Ellen Lintal

Chief Financial Officer

AIM · AIM ImmunoTech Inc.

Effective: 2022-03-31
Filed: September 21, 2021, 7:59 PM ET

On September 20, 2021, Ellen Lintal informed the Registrant that she intended to retire as Chief Financial Officer effective March 31, 2022 and, therefore, will not be renewing her contract.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Ellen Lintal retired as Chief Financial Officer at AIM ImmunoTech Inc..

Action: retired
Role: Chief Financial Officer

Exact text from the filing

On September 20, 2021, Ellen Lintal informed the Registrant that she intended to retire as Chief Financial Officer effective March 31, 2022 and, therefore, will not be renewing her contract.

View on SEC.gov

AIM ImmunoTech Inc. filing history →

Source: SEC EDGAR

accession 0001493152-21-023270

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.